Predictive Value of the PBS-score in Children With Clubfoot
Launched by REGION STOCKHOLM · Sep 17, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the PBS-score to see how well it can predict whether children with clubfoot will need more treatment in the future. Clubfoot is a condition where a child's foot is twisted out of shape, and the goal of this study is to help doctors understand which children might be more likely to need additional care after their initial treatment.
To participate in this trial, children must be between 4 and 10 years old, have been diagnosed with idiopathic clubfoot (which means it’s not caused by another syndrome), and be able to walk and communicate in English or Swedish. The trial is currently looking for participants, and families can expect to be involved in assessments that will help determine how useful the PBS-score is in managing their child's condition. This research could lead to better treatment plans and outcomes for children with clubfoot in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 4-10 years, a diagnosis of idiopathic clubfoot, ability to walk 10 m repeatedly, and ability to communicate verbally (and in writing for caregivers) in Swedish or English.
- Exclusion Criteria:
- • Syndromic clubfoot
About Region Stockholm
Region Stockholm is a leading healthcare authority committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Stockholm collaborates with hospitals, research institutions, and industry partners to facilitate the development of new therapies and treatment protocols. With a focus on quality, safety, and ethical standards, the organization aims to enhance health outcomes for the diverse population of Stockholm and beyond, leveraging cutting-edge research to translate scientific discoveries into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, Region Stockholm, Sweden
Patients applied
Trial Officials
Eva W Broström, Professor
Principal Investigator
Astrid Lindgren Children´s Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported